Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

Kamran Ghoreschi, Jürgen Brück, Christina Kellerer, Caishu Deng, Haiyan Peng, Oliver Rothfuss, Rehana Z. Hussain, Anne R. Gocke, Annedore Respa, Ivana Glocova, Nadejda Valtcheva, Eva Alexander, Susanne Feil, Robert Feil, Klaus Schulze-Osthoff, Rudolf A. Rupec, Amy E. Lovett-Racke, Ralf Dringen, Michael K. Racke, Martin Röcken

Research output: Contribution to journalArticle

Abstract

Fumarates improve multiple sclerosis (MS) and psoriasis, two diseases in which both IL-12 and IL-23 promote pathogenic T helper (Th) cell differentiation. However, both diseases show opposing responses to most established therapies. First, we show in humans that fumarate treatment induces IL-4-producing Th2 cells in vivo and generates type II dendritic cells (DCs) that produce IL-10 instead of IL-12 and IL-23. In mice, fumarates also generate type II DCs that induce IL-4-producing Th2 cells in vitro and in vivo and protect mice from experimental autoimmune encephalomyelitis. Type II DCs result from fumarateinduced glutathione (GSH) depletion, followed by increased hemoxygenase-1 (HO-1) expression and impaired STAT1 phosphorylation. Induced HO-1 is cleaved, whereupon the N-terminal fragment of HO-1 translocates into the nucleus and interacts with AP-1 and NF-κB sites of the IL-23p19 promoter. This interaction prevents IL-23p19 transcription without affecting IL-12p35, whereas STAT1 inactivation prevents IL-12p35 transcription without affecting IL-23p19. As a consequence, GSH depletion by small molecules such as fumarates induces type II DCs in mice and in humans that ameliorate inflammatory autoimmune diseases. This therapeutic approach improves Th1- and Th17-mediated autoimmune diseases such as psoriasis and MS by interfering with IL-12 and IL-23 production.

Original languageEnglish (US)
Pages (from-to)2291-2303
Number of pages13
JournalJournal of Experimental Medicine
Volume208
Issue number11
DOIs
StatePublished - Oct 24 2011

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells'. Together they form a unique fingerprint.

  • Cite this

    Ghoreschi, K., Brück, J., Kellerer, C., Deng, C., Peng, H., Rothfuss, O., Hussain, R. Z., Gocke, A. R., Respa, A., Glocova, I., Valtcheva, N., Alexander, E., Feil, S., Feil, R., Schulze-Osthoff, K., Rupec, R. A., Lovett-Racke, A. E., Dringen, R., Racke, M. K., & Röcken, M. (2011). Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. Journal of Experimental Medicine, 208(11), 2291-2303. https://doi.org/10.1084/jem.20100977